Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
PRAME : Essai de phase 1, en escalade de dose, évaluant la tolérance et l'immunogénicité d’une immunothérapie recPRAME + AS15, en traitement adjuvant, chez des patients PRAME+.ayant un cancer du poumon non à petites cellules opérable. [essai clos aux inclusions] https://kusajili.fr:443/Trial/leZ1Gy788U6slZ8oEUufyQ%24prame-essai-de-phase-1-en-escalade-de-dose-evaluant-la-tolerance-et-limmunogenicite-dune-immunotherapie-recprame-as15-en-traite
I have read and accept the terms of use of the site and the Privacy Policy
Send your message